This site is intended for healthcare professionals

Adjuvant treatment with Opdivo shows statistically significant and clinically meaningful improvement in disease-free survival for muscle-invasive urothelial carcinoma in phase III CheckMate -274 trial.- BMS

Read time: 1 mins
Last updated:10th Feb 2021
Published:10th Feb 2021
Condition: Bladder Cancer
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest